NEUROPHET, Inc. (KOSDAQ:380550)
South Korea · Delayed Price · Currency is KRW 14,650
-430 (-2.85%)
Aug 14, 2025, 2:40 PM KST
NEUROPHET Market Cap
NEUROPHET has a market cap or net worth of 168.47 billion as of August 14, 2025.
Market Cap
168.47B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
14,650.00
Market Cap Chart
Since July 25, 2025, NEUROPHET's market cap has decreased from 232.96B to 168.47B, a decrease of -27.68%. That is a compound annual growth rate of -99.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 173.06B | 0.60% |
| Aug 12, 2025 | 172.03B | -2.98% |
| Aug 11, 2025 | 177.30B | -4.51% |
| Aug 8, 2025 | 185.68B | 5.41% |
| Aug 7, 2025 | 176.16B | -4.00% |
| Aug 6, 2025 | 183.50B | -2.44% |
| Aug 5, 2025 | 188.09B | 9.19% |
| Aug 4, 2025 | 172.26B | 3.66% |
| Aug 1, 2025 | 166.17B | -8.76% |
| Jul 31, 2025 | 182.12B | -7.30% |
| Jul 30, 2025 | 196.47B | -10.32% |
| Jul 29, 2025 | 219.08B | -3.44% |
| Jul 28, 2025 | 226.88B | -2.61% |
| Jul 25, 2025 | 232.96B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 73.45T |
| Celltrion | 38.14T |
| ALTEOGEN | 22.98T |
| Yuhan | 8,383.50B |
| SK Biopharmaceuticals | 7,737.35B |
| PharmaResearch | 7,064.96B |
| Peptron | 6,989.21B |
| LigaChem Biosciences | 5,419.69B |